Measuring the Impact of the COVID-19 Pandemic on Diagnostic Delay in Rare Disease
Rare diseases are individually rare but collectively common, with a combined prevalence of 3.5–5.9%. A common feature of many diseases is a substantial delay in patients receiving a correct diagnosis; this protracted path to diagnosis is termed ‘the diagnostic odyssey’. During the COVID-19 pandemic...
Saved in:
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
European Medical Journal
2022-07-01
|
Series: | European Medical Journal |
Online Access: | https://www.emjreviews.com/innovations/article/measuring-the-impact-of-the-covid-19-pandemic-on-diagnostic-delay-in-rare-disease/ |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|